Actinium Pharmaceuticals, Inc. (NYSE:ATNM) Given Consensus Recommendation of “Moderate Buy” by Analysts
Shares of Actinium Pharmaceuticals, Inc. (NYSE:ATNM – Get Free Report) have received a consensus rating of “Moderate Buy” from the five analysts that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month target price among […]
19 Nov 06:39 · The Cerbat Gem